4//SEC Filing
DANON URI 4
Accession 0001140361-10-000313
CIK 0001451980other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 9:06 AM ET
Size
6.0 KB
Accession
0001140361-10-000313
Insider Transaction Report
Form 4
BIOCANCELL THERAPEUTICS INC.BICL.TA
DANON URI
Chief Executive Officer
Transactions
- Award
Option to Purchase Common Stock
2009-12-31+450,000→ 450,000 totalExp: 2019-12-31→ Common Stock, par value $0.01 (450,000 underlying)
Footnotes (2)
- [F1]The exercise price is 3.18 NIS per share.
- [F2]80,000 options shall vest and be exercisable immediately, and 23,125 options shall vest and be exercisable at the end of 16 consecutive calendar quarters commencing December 31, 2009, provided, however, that the vesting of some options will be accelerated if pre-set milestones are achieved by pre-set dates.
Documents
Issuer
BIOCANCELL THERAPEUTICS INC.
CIK 0001451980
Entity typeother
Related Parties
1- filerCIK 0001475459
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 9:06 AM ET
- Size
- 6.0 KB